Clinical Trial Update: Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating pooled allogenic mesenchymal stem cells for systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• pooled allogenic mesenchymal stem cells

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Systemic Lupus Erythematosus | Phase 1, Phase 2 | Status: COMPLETED